Form 4: Zimmer Biomet Director Maria Teresa Hilado Reports Phantom Stock Unit Acquisition

Director Maria Teresa Hilado reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. through a deferred compensation plan.

Summary

• Maria Teresa Hilado, a director of Zimmer Biomet Holdings, Inc., filed a Form 4 on January 3, 2025, reporting a transaction that occurred on December 31, 2024.
• The transaction involved the acquisition of 260.096 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion price of the derivative security is 1-for-1.
• These units will be settled in cash in five annual installments, starting within sixty days after the end of the calendar year in which Hilado's service as a director ends.
• Following the reported transaction, Hilado beneficially owns 9,039.055 phantom stock units.
• This amount includes 19.439 phantom stock units accrued on October 31, 2024, under the dividend reinvestment provision of the plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard disclosure of a transaction related to director compensation.

Future Outlook

The phantom stock units will be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Industry Context

This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. It provides transparency into the equity-based compensation of board members.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding director compensation.

Key Dates